Dr. Nathan and Dr. Patel Discuss a Challenging Case in Diagnosing PF-ILD
About this Episode
Interstitial lung disease (ILD) describes a group of over more than 200 rare pulmonary conditions characterized by fibrosis of the lung. ILD can have several causes, including environmental antigens, bacterial, viral, and fungal infections, gastroesophageal reflux, occupational hazards (eg, asbestos), or a connective tissue disease (CTD). Patients with systemic sclerosis (SSc), rheumatoid arthritis (RA), or poly-/dermatomyositis (PM/DM), have the greatest risk of developing CTD-associated ILD. Idiopathic pulmonary fibrosis (IPF) is the most common ILD, though patients who develop a progressive-fibrosing phenotype ILD (PF-ILD) are subject to similar outcomes. With historically limited treatment options, pulmonologists, rheumatologists, radiologists, and other providers who care for patients with PF-ILD are unaware of how new options and data for patients with IPF may benefit patients with PF-ILD. In this educational activity, expert clinicians will discuss a challenging case on diagnosing a patient with PF-ILD.
Transcript: https://tinyurl.com/PF-ILD3Transcript
For CME Credit, complete activity here: https://tinyurl.com/PF-ILD3
Recent Episodes from MedEdTalks - Pulmonology
Updates on the Use of Neoadjuvant and Adjuvant IO in Patients With NSCLC With Drs. Laurie Carr and Heather Wakelee
Updates in IO for Advanced NSCLC – Options for First-line Treatment and Management of Progressive Disease With Drs. Laurie Carr and Heather Wakelee
NSCLC: Updates in Testing and Interpreting Results – Focus on IO With Drs. Laurie Carr and David Ross Camidge
NSCLC: Optimizing Care Coordination – Through the Patient and Caregiver’s Eyes
Lung Cancer Advances and Challenges During a Pandemic – Where Do We Go From Here? With Drs. Jeffrey Kern and Charu Aggarwal
The Importance of Patient Education on Adherence to Therapies in IPF with Drs. Robert J. Kaner and Maria Padilla
In this podcast, expert clinicians will discuss best practice for improving patient-provider communication to improve adherence to IPF therapies.
Long-term Outcomes with IPF Therapies with Drs. Maria Padilla and Steven D. Nathan, MD
In this podcast, expert clinicians will discuss the most recent data regarding long-term outcomes with current therapies for IPF.
The Importance of Early and Accurate Diagnosis in IPF with Drs. Maria Padilla and Robert J. Kaner
In this podcast, expert clinicians will discuss evidence-based best practices for making early and accurate diagnoses in IPF.
Improving Adherence: Patient Engagement and Education With Drs. Elizabeth R. Volkmann and Kristin B. Highland
In this podcast, expert clinicians will discuss the strategies to improve patients adherence to therapy in SSc-ILD.